ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.

Varun V Prabhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.